Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Gossamer Bio, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −15 vs. Q1 2024
- Shares held
- 182.9M
- −14.9M (−7.6%) vs. Q1 2024
- Total value
- $164.7M
- −$68.8M (−29.5%) vs. Q1 2024
- New holders
- 11
- 31 more added
- Sold out
- 26
- 29 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOSS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $60.8M |
| Q1 2026 | 185 | $56.3M |
| Q4 2025 | 195 | $573.4M |
| Q3 2025 | 164 | $473.7M |
| Q2 2025 | 124 | $218.0M |
| Q1 2025 | 119 | $186.9M |
| Q4 2024 | 105 | $155.0M |
| Q3 2024 | 100 | $172.6M |
| Q2 2024 | 94 | $164.7M |
| Q1 2024 | 109 | $233.5M |
| Q4 2023 | 98 | $192.0M |
| Q3 2023 | 96 | $171.2M |
| Q2 2023 | 99 | $74.4M |
| Q1 2023 | 111 | $97.9M |
| Q4 2022 | 120 | $225.1M |
| Q3 2022 | 160 | $1.02B |
| Q2 2022 | 129 | $533.2M |
| Q1 2022 | 141 | $519.8M |
| Q4 2021 | 133 | $664.9M |
| Q3 2021 | 128 | $687.7M |
| Q2 2021 | 115 | $431.1M |
| Q1 2021 | 123 | $501.9M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Gossamer Bio, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −300,034−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −210,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −180,987−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −144,949−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −140,083−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −98,036−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −90,806−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −64,600−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −53,600−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −52,575−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −49,500−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −42,536−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −29,935−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −28,520−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −21,377−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −16,907−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,433−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −9,271−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −4−100.0% | Sold out |